Live News Categoriesmarket

ACON.O (ACON.O) News

Follow ACON.O (ACON.O) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 1 public stories across 1 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol ACON.O Asset market Sector Markets 90 days 1 Updated Sep 29, 2026, 11:07 AM UTC Open live news feed

M Aclarion adds NYU Langone Health as enrolling site for CLARITY trial of Nociscan Aclarion says NYU Langone Health has been added as a new enrolling site for its ongoing CLARITY randomized trial of Nociscan in spine surgery; outcomes are to be assessed at 12 months. EQUITY | Sep 29, 2026, 11:07 AM UTC